Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease
Open Access
- 1 April 2012
- journal article
- review article
- Published by Elsevier BV in Neurotherapeutics
- Vol. 9 (2), 270-284
- https://doi.org/10.1007/s13311-012-0112-2
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- Activated microglia proliferate at neurites of mutant huntingtin-expressing neuronsNeurobiology of Aging, 2012
- Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor functionNeuroscience, 2011
- Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's diseaseFree Radical Biology & Medicine, 2010
- Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatumNeuropharmacology, 2010
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD MiceNeuron, 2009
- Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtinNature Medicine, 2009
- Sustained effects of nonallele‐specific Huntingtin silencingAnnals of Neurology, 2009
- Mitochondrial calcium function and dysfunction in the central nervous systemBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's diseaseNeurobiology of Disease, 2008
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004